Ever Fortune AI signs long-term deal with Temasek kidney device firm

Ever Fortune AI (Chang Gung Intelligent) has signed a 15-year technology transfer and co-development agreement with a Temasek-owned kidney disease medical device company, expected to generate $37-38 million in revenue.

“與淡馬錫投控旗下腎臟病醫材公司簽定長約，初估營收貢獻超過 10 億元”news.cnyes.com

• 1 source
• news.cnyes.com長佳智能拿下腎病醫材長約 營收貢獻上看10億元 | 鉅亨網 - 台股新聞Jan 17, 2023

Summarized from public sources; check the original articles before acting on it.